ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
NCT06801899 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170
Last updated 2025-09-30
Summary
The goal of this clinical trial is to learn if total removal of the pancreas is a preferable alternative to partial removal in patients with cancer of the pancreatic head who are at high risk of pancreatic leakage. The main question it aims to answer is:
Does total pancreas removal improve survival without reducing quality of life compared to partial removal?
The only study specific procedures are the collection of 2 blood samples (7.5ml for each time point, preoperatively and during the hospitalisation) and the completion of the questionnaires.
Conditions
Interventions
- PROCEDURE
-
Total pancreatectomy (TP)
The investigators perform TP in patients who undergo surgical resection of a malignant tumor in the pancreatic head.
- PROCEDURE
-
Partial pancreaticoduodenectomy (PD)
The investigators perform partial PD with anastomosis of the pancreas in patients who undergo surgical resection of a malignant tumor in the pancreatic head. This is the current standard procedure.
Sponsors & Collaborators
-
Insel Gruppe AG, University Hospital Bern
lead OTHER
Principal Investigators
-
Anna S Wenning, MD, PhD · Department of Visceral Surgery and Medicine Inselspital, Bern University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-12
- Primary Completion
- 2029-07-31
- Completion
- 2029-07-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma
NCT03649035 ·Status: WITHDRAWN ·Phase: PHASE3
-
Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma
NCT05525286 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer
NCT01569282 ·Status: WITHDRAWN ·Phase: NA
-
Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
NCT00003029 ·Status: COMPLETED ·Phase: PHASE3
-
Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
NCT00030732 ·Status: COMPLETED ·Phase: PHASE3
-
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
NCT01192763 ·Status: TERMINATED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
NCT00002955 ·Status: COMPLETED ·Phase: PHASE2
-
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
NCT06980792 ·Status: COMPLETED
-
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
NCT06998940 ·Status: RECRUITING ·Phase: PHASE3
-
Surgical Results of Resection of Locally Advanced Pancreatic Cancer
NCT06206382 ·Status: NOT_YET_RECRUITING
-
Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients
NCT01198522 ·Status: TERMINATED ·Phase: PHASE1
-
Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
NCT06122480 ·Status: TERMINATED ·Phase: NA
-
Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
NCT00003049 ·Status: COMPLETED ·Phase: PHASE3
-
Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
NCT03970252 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pancreas-sparing Duodenectomy Versus Pancreatoduodenectomy for Early-stage Periampullary Carcinoma
NCT01291927 ·Status: UNKNOWN ·Phase: NA
-
Using Tumor Models to Determine Treatments
NCT06813079 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
NCT04390399 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Management of Symptomatic Advanced Pancreatic Adenocarcinoma
NCT02979483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.
NCT07148830 ·Status: RECRUITING ·Phase: NA
-
Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
NCT00003025 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
NCT07081360 ·Status: RECRUITING ·Phase: PHASE3
-
Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer
NCT00003085 ·Status: TERMINATED ·Phase: PHASE2
-
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
NCT05040360 ·Status: RECRUITING ·Phase: PHASE2
-
Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
NCT07340151 ·Status: RECRUITING ·Phase: NA
-
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
NCT01013649 ·Status: COMPLETED ·Phase: PHASE3